Dietary-induced hyperparathyroidism affects serum and gingival proinflammatory cytokine levels in rats

Journal of Periodontology

Volumn 81, Issue 1, 2010, Pages 150-157

  Lütfioǧlu, Müge ^a   Sakallioǧlu, Umur ^a   Sakallioǧlu, E Eser ^a   Diraman, Emine ^a   Çiftçi, Gülay ^a   Tutkun, Ferda ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Cytokines; Diet; Interleukin 1beta; Parathyroid hormone; Periodontal diseases; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL FOOD; ARTICLE; BLOOD; DISEASE MODEL; GINGIVA; HYPERPARATHYROIDISM; IMMUNOLOGY; METABOLISM; PERIODONTITIS; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMAL FEED; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; GINGIVA; HYPERPARATHYROIDISM; INTERLEUKIN-1BETA; PARATHYROID HORMONE; PERIODONTITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77649196561     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090353     Document Type: Article

References (57)

1. Boyd LD, Madden TE. Nutrition, infection and periodontal disease. Dent Clin North Am 2003;47:337-354.
2. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005;7:3-7.
3. Neiva RF, Steigenga J, Al-Shammari KF, Wang HL. Effects of specific nutrients on periodontal disease onset, progression and treatment. J Clin Periodontol 2003;30:579-589.
4. Vender I, Lovely FW, York SE. Lamina dura and other metabolic changes in hyperparathyroidism. J Can Dent Assoc (Tor) 1971;37:261-264.
5. Kaffee I, Tamse A, Schwartz Y, Buchner A, Littner MM. Changes in the lamina dura as a manifestation of systemic diseases: Report of a case and review of the literature. J Endod 1982;8:467-470.
6. Triantafillidou K, Zouloumis L, Karakinaris G, Kalimeras E, Iordanidis F. Brown tumors of the jaws associated with primary or secondary hyperparathyroidism. A clinical study and review of the literature. Am J Otolaryngol 2006;27:281-286.
7. Frankenthal S, Nakhoul F, Machtei EE, et al. The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium. J Clin Periodontol 2002;29:479-483.
8. Padbury AD, Tözüm TF, Taba M Jr., et al. The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab 2006;91:3439-3445.
9. Roberts WE. Cell population dynamics of periodontal ligament stimulated with parathyroid extract. Am J Anat 1975;143:363-370.
10. Rao LG, Moe HK, Heersche JN. In-vitro culture of porcine periodontal ligament cells: Response of fibroblast- like and epithelial-like cells to prostaglandin E1, parathyroid hormone and calcitonin and separation of a pure population of fibroblast-like cells. Arch Oral Biol 1978;23:957-964.
11. Lindskog S, Blomlöf L, Hammarström L. Comparative effects of parathyroid hormone on cementoblasts and osteoblasts. J Clin Periodontol 1987;14:386-389.
12. Ogata Y, Niisato N, Sakurai T, Furuyoma S, Sugiya H. Comparison of the characteristic of human gingival fibroblasts and periodontal ligament cells. J Periodontol 1995;66:1025-1031.
13. Calvo MS, Kumar R, Heath H 3rd. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab 1988;66:823-829.
14. Calvo MS, Kumar R, Heath H 3rd. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab 1990; 70:1334-1340.
15. Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int 2009;75:898-905.
16. Kristensen M, Jensen M, Kudsk J, Henriksen M, Mølgaard C. Short-term effects on bone turnover of replacing milk with cola beverages: A 10-day interventional study in young men. Osteoporos Int 2005; 16:1803-1808.
17. Koshihara M, Katsumata S, Uehara M, Suzuki K. Effects of dietary phosphorus intake on bone mineralization and calcium absorption in adult female rats. Biosci Biotechnol Biochem 2005;69:1025-1028. (Pubitemid 41006979)
18. Huttunen MM, Pietilä PE, Viljakainen HT, Lamberg- Allardt CJ. Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats. J Nutr Biochem 2006;17:479-484.
19. Sax L. The institute of medicine's "dietary reference intake" for phosphorus: A critical perspective. J Am Coll Nutr 2001;20:271-278.
20. Kemi VE, Kärkkäinen MU, Karp HJ, Laitinen KA, Lamberg-Allardt CJ. Increased calcium intake does not completely counteract the effects of increased phosphorus intake on bone: An acute dose-response study in healthy females. Br J Nutr 2008;99:832-839.
21. Bissada NF, DeMarco TJ. The effect of hypocalcemic diet on the periodontal structures of the adult rat. J Periodontol 1974;45:739-745.
22. Whalen JP, Krook L. Periodontal disease as the early manifestation of osteoporosis. Nutrition 1996;12:53-54.
23. Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. Calcium and the risk for periodontal disease. J Periodontol 2000;71:1057-1066.
24. Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997;30: 606-620.
25. Alexiewicz JM, Klinger M, Pitts TO, Gaciong Z, Linker- Israeli M, Massry SG. Parathyroid hormone inhibits B cell proliferation: Implications in chronic renal failure. J Am Soc Nephrol 1990;1:236-244.
26. Alexiewicz JM, Gaciong Z, Klinger M, Linker-Israeli M, Pitts TO, Massry SG. Evidence of impaired T cell function in hemodialysis patients: Potential role for secondary hyperparathyroidism. Am J Nephrol 1990; 10:495-501.
27. Kotzmann H, Köller M, Abela C, et al. Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism. Eur J Clin Invest 1998;28:353-358.
28. Chertok-Shacham E, Ishay A, Lavi I, Luboshitzky R. Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism. Med Sci Monit 2008; 14:CR628-CR632.
29. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - A clinical research center study. J Clin Endocrinol Metab 1996;81:3450-3454.
30. Grey A, Mitnick MA, Masiukiewicz U, et al. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 1999;140:4683-4690.
31. Türk S, Akbulut M, Yildiz A, et al. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: The effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron 2002;90: 188-194.
32. Santos FR, Moyses RM, Montenegro FL, Jorgetti V, Noronha IL. IL-1β TNF-α, TGF-β, and bFGF expression in bone biopsies before and after parathyroidectomy. Kidney Int 2003;63:899-907.
33. Demeter JG, De Jong SA, Oslapas R, et al. High phosphate diet-induced primary hyperparathyroidism: An animal model. Surgery 1991;110:1053-1060.
34. Zhang Y, Lai WP, Leung PC, Wu CF, Wong MS. Shortto mid-term effects of ovariectomy on bone turnover, bone mass and bone strength in rats. Biol Pharm Bull 2007;30:898-903.
35. Llavaneras A, Ramamurthy N, Heikkila P, et al. A combination of chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxininduced periodontal breakdown in rats. J Periodontol 2001;72:1069-1077.
36. Sakallioǧlu EE, Aliyev E, Lütfioǧlu M, Yavuz U, Açikgöz G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig 2007;11:115-120.
37. Ngan PW, Crock B, Varghese J, Lanese R, Shanfeld J, Davidovitch Z. Immunohistochemical assessment of the effect of chemical and mechanical stimuli on cAMP and prostaglandin E levels in human gingival fibroblasts in vitro. Arch Oral Biol 1988;33:163-174.
38. Sjöström S, Hanström L, Lerner UH. The bone resorbing activity released by gingival fibroblasts isolated from patients with periodontitis is independent of interleukin-1. J Periodontal Res 2000;35:74-84.
39. Lutwak L, Krook L, Henrikson PA, et al. Calcium deficiency and human periodontal disease. Isr J Med Sci 1971;7:504-505.
40. Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970;49:2146-2149.
41. Katsumata S, Matsuzaki H, Uehara M, Suzuki K. Effects of lowering food intake by high phosphorus diet on parathyroid hormone actions and kidney mineral concentration in rats. Biosci Biotechnol Biochem 2006;70:528-531.
42. Masuyama R, Uehara M, Suzuki K. High P diet induces acute secretion of parathyroid hormone without alteration of serum calcium levels in rats. Biosci Biotechnol Biochem 2000;64:2316-2319.
43. van Doorn L, Lips P, Netelenbos JC, Hackeng WH. Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism. Bone Miner 1993; 23:233-242.
44. Kemi VE, Kärkkäinen MU, Lamberg-Allardt CJ. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr 2006;96: 545-552.
45. Karp HJ, Vaihia KP, Kärkkäinen MU, Niemistö MJ, Lamberg-Allardt CJ. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: A whole-foods approach. Calcif Tissue Int 2007;80:251-258.
46. Ritskes-Hoitinga J, Mathot JN, Lemmens AG, et al. Long-term phosphorus restriction prevents corticomedullary nephrocalcinosis and sustains reproductive performance but delays bone mineralization in rats. J Nutr 1993;123:754-763.
47. Duarte ME, Carvalho EF, Cruz EA, Lucena SB, Andress DL. Cytokine accumulation in osteitis fibrosa of renal osteodystrophy. Braz J Med Biol Res 2002;35:25-29.
48. Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000;18:1207-1213.
49. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002;17:1684-1688.
50. Stenvinkel P, Heimbürger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002;39:274-282.
51. Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007;292: F1215-F1218. (Pubitemid 46572440)
52. Chervu I, Kiersztejn M, Alexiewicz JM, Fadda GZ, Smogorzewski M, Massry SG. Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism. Kidney Int 1992;41:1501-1505.
53. Perry HM 3rd, Chappel JC, Bellorin-Font E, Tamao J, Martin KJ, Teitelbaum SL. Parathyroid hormone receptors in circulating human mononuclear leukocytes. J Biol Chem 1984;259:5531-5535.
54. Shurtz-Swirski R, Shkolnik T, Shasha SM. Parathyroid hormone and the cellular immune system. Nephron 1995;70:21-24.
55. Safley SA, Villinger F, Jackson EH, Tucker-Burden C, Cohen C, Weber CJ. Interleukin-6 production and secretion by human parathyroids. Clin Exp Immunol 2004;136:145-156.
56. Deicher R, Kirsch B, Müllner M, Kaczirek K, Niederle B, Hörl WH. Impact of parathyroidectomy on neutrophil cytosolic calcium in chronic kidney disease patients: A prospective parallel group trial. J Intern Med 2005;258:67-76.
57. Griveas I, Visvardis G, Papadopoulou D, et al. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis. Ren Fail 2005;27: 275-278.